Calcitonin gene-related peptide, substance P and nitric oxide are involved in cutaneous inflammation following ultraviolet irradiation

European Journal of Pharmacology
J BenrathF Gillardon


Evidence from our previous work suggests that neurogenic mediators contribute to the inflammation following ultraviolet (UV) irradiation of the skin. We have investigated whether calcitonin gene-related peptide (CGRP), substance P and nitric oxide (NO) participate in the cutaneous inflammatory reaction of the rat hind paw and ear to UV irradiation. Skin blood flow was measured by laser Doppler technique. Oedema was quantified using a spring loaded micrometer to measure ear thickness. UV irradiation of the rat skin lead to a long lasting increase in skin blood flow. This increase was dose dependently attenuated by the CGRP receptor antagonist CGRP-(8-37) (0.15 nmol in 25 microliters to 6.0 nmol in 25 microliters, s.c.) up to 51% with a maximum of effectiveness at 24 h post irradiation. The inhibitor of NO synthase NG-nitro-L-arginine methyl ester hydrochloride (L-NAME, 25 nmol in 25 microliters, s.c.) attenuated skin blood flow by 38%. Concurrent injections s.c. of CGRP-(8-37) (1.5 nmol in 12.5 microliters) and L-NAME (25 nmol in 12.5 microliters) demonstrated an augmentive effect in attenuating skin blood flow. The tachykinin NK1 receptor antagonist CP-96,345 (6.0 nmol in 25 microliters, s.c.) attenuated skin blood flow by 27%....Continue Reading


Jun 30, 1992·Annals of the New York Academy of Sciences·I Marshall
Mar 1, 1992·International Journal of Dermatology·P CappugiT Lotti
Mar 1, 1992·Trends in Neurosciences·S R Vincent, B T Hope
Jun 30, 1992·Annals of the New York Academy of Sciences·S D BrainP Wilsoncroft
Sep 28, 1990·Biochemical and Biophysical Research Communications·S M GardinerB Hughes
Jun 1, 1988·Agents and Actions·E I HarperR A Brown
Jan 3, 1985·Nature·S D BrainI MacIntyre
Oct 1, 1985·Photochemistry and Photobiology·A R YoungH I Maibach
Sep 1, 1967·British Journal of Pharmacology and Chemotherapy·N JancsóJ Szolcsányi

❮ Previous
Next ❯


Oct 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Boris A Chizh, Christine N Sang
Mar 18, 2000·Neuroscience Research·N Yonehara, M Yoshimura
Jun 8, 2002·Neuroscience Letters·Susan M Carlton, Richard E Coggeshall
Feb 11, 1998·General Pharmacology·P Holzer
Oct 31, 2001·Journal of Photochemistry and Photobiology. B, Biology·M Norval
Apr 16, 2003·Journal of Photochemistry and Photobiology. B, Biology·Annemarie SleijffersJohan Garssen
Sep 17, 2002·Methods : a Companion to Methods in Enzymology·Kristina Seiffert, Richard D Granstein
Aug 23, 2001·International Immunopharmacology·R Ross, A B Reske-Kunz
Nov 23, 2000·British Journal of Pharmacology·N E SaadéS A Kanaan
Mar 4, 2000·European Journal of Pain : EJP·R T Hoffmann, M Schmelz
Jul 5, 2012·PloS One·Benjamin WeinkaufMartin Schmelz
Oct 19, 2013·Science·Daniel HuberJoshua N Winn
Oct 9, 1998·The Journal of Investigative Dermatology·J K LaihiaC T Jansen
Jan 27, 2009·Brain Research Reviews·Boris A ChizhKlaus Schaffler
Jan 11, 2007·British Journal of Pharmacology·J-s QiB P Damiano
Jul 23, 2008·The Journal of Pharmacy and Pharmacology·Helen O McCarthyDavid G Hirst
Dec 24, 2014·Acta Physiologica·R D GransteinW Ding
Apr 28, 2004·European Journal of Pain : EJP·Wolfgang KoppertMartin Schmelz
Feb 22, 2011·Brain, Behavior, and Immunity·Jing HuangRichard D Granstein
Apr 14, 1999·The Journal of Investigative Dermatology·H NiizekiJ W Streilein
Dec 20, 2000·The Journal of Investigative Dermatology·T Kitazawa, J W Streilein
Nov 1, 1996·Biomedical Chromatography : BMC·T M Phillips
Feb 9, 2006·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Franz J Legat, Peter Wolf
Jan 1, 2019·Astrophysics and Space Science·Sowgata ChowdhuryK T Paul
Oct 30, 2008·Journal of Immunotoxicology·Annemarie SleijffersHenk Loveren
Jul 18, 2017·Oncology Reports·Mihai LupuAristides M Tsatsakis
Feb 21, 2003·International Journal of Immunopathology and Pharmacology·S. KasaharaE. L. Cooper
May 19, 2000·Annals of the New York Academy of Sciences·J W StreileinH Niizeki
Dec 19, 2018·Frontiers in Medicine·Franz J Legat

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.